N/A
N=46
Prevention of Preterm Birth With a Pessary in Twin Gestations
Premature Birth · Short Cervix
Bottom Line
View on ClinicalTrials.gov: NCT02056639 ↗Enrolled (actual)
46
Serious AEs
0.0%
Results posted
May 2018
Primary outcome: Primary: Number of Participants With Preterm Delivery — 9; 8 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Bioteque cup pessary (Device)
- Age
- Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Pennsylvania
- Primary completion
- Aug 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Preterm Delivery |
9; 8 | — |
| SECONDARY Average Birth Weight of Babies in Each Group |
2190; 2220 | — |
| SECONDARY Spontaneous Preterm Birth Rates |
12; 12 | — |
| SECONDARY Number of Participants That Experienced Neonatal Death |
4; 3 | — |
| SECONDARY Number of Subjects Experiencing Chorioamnionitis |
3; 0 | — |
Summary
Preterm birth (PTB) is a major health problem and contributes to more than 50% of the overall perinatal mortality. Twins are at increased risk for PTB. The number of twins births has risen substantially due to the increased use of assisted reproductive technology. The rate of twin births in the United States rose from 18.9 to 32.2 per 100 live births between 1980 and 2004. The increased rate of PTB in twins is associated with increased morbidity and mortality rates. Almost one in four very low birth-weight infants (below 1500 g) born in the United States are twins, as are one in six infants who die in the first month of life. Cervical shortening is a risk factor for PTB. Transvaginal ultrasound measurement of cervical length is a reliable screening test for prediction of PTB. There is currently no effective treatment to decrease the incidence of PTB in women with twin gestations, but there is some evidence that the use of a cervical pessary in women with a short cervix has promise. If effective this approach would be particularly appealing because of the wide availability of pessaries, ease of use, and low cost. Unfortunately, existing studies are inadequate to confirm effectiveness; a well designed, properly powered, prospective randomized trial is warranted prior to widespread implementation in clinical practice. We propose such a trial to study the effectiveness of the pessary in decreasing the incidence of PTB in an inner city Philadelphia population.
Eligibility Criteria
Inclusion Criteria
- 18-50 years of age
- Twin pregnancy (limits the participants to female gender)
- Short cervical length (less than or equal to 30 mm) on second trimester ultrasound at 18-27 6/7 weeks gestation
Exclusion Criteria
- Singleton or higher order than twins multiple gestation
- Monoamniotic twins
- Twin twin transfusion syndrome
- Ruptured membranes
- Lethal fetal structural anomaly
- Fetal chromosomal abnormality
- Cerclage in place (or planned placement)
- Vaginal bleeding
- Suspicion of chorioamnionitis
- Ballooning of membranes outside the cervix into the vagina
- Painful regular uterine contractions
- Labor
- Placenta previa
Data sourced from ClinicalTrials.gov (NCT02056639). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.